Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2020
Altered Macrophage Polarization Induces Experimental Pulmonary Hypertension and Is Observed in Patients With Pulmonary Arterial HypertensionAmira Zawia, Nadine D Arnold, Laura West, et al.
ERJ Open Research|June 18, 2024
A serum calprotectin lateral flow test as an inflammatory and prognostic marker in acute lung infection: a prospective observational studyAmy Gilmour, Chloe Hughes, Yan Hui Giam, et al.
Pulmonary Circulation|December 21, 2017
Selective improvement of pulmonary arterial hypertension with a dual ETA/ETB receptors antagonist in the apolipoprotein E-/- model of PAH and atherosclerosisLewis Renshall, Nadine Arnold, Laura West, et al.
International Journal of Cardiology|September 21, 2022
Atrial flutter and fibrillation in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension in the ASPIRE registry: Comparison of rate versus rhythm control approachesMark Anthony Sammut, Robin Condliffe, Charlie Elliot, et al.
American Journal of Respiratory and Critical Care Medicine|May 9, 2025
Clustering Pulmonary Hypertension Patients Using the Plasma ProteomeAthénaïs Boucly, Shanshan Song, Merve Keles, et al.
Chest|May 15, 2007
Endogenous urate production augments plasma antioxidant capacity in healthy lowland subjects exposed to high altitudeJ Kenneth Baillie, Matthew G D Bates, A A Roger Thompson, et al.
Radiology|February 6, 2024
Improving Prognostication in Pulmonary Hypertension Using AI-quantified Fibrosis and Radiologic Severity Scoring at Baseline CTKrit Dwivedi, Michael Sharkey, Liam Delaney, et al.
The European Respiratory Journal|February 29, 2020
Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertensionRobert A Lewis, A A Roger Thompson, Catherine G Billings, et al.
Annals of the American Thoracic Society|October 15, 2024
Do Hemodynamic Definitions of Chronic Thromboembolic Pulmonary Hypertension Distinguish between Distinct Phenotypes of Chronic Thromboembolic Pulmonary Disease?Ellis Cerrone, Abdul G Hameed, David G Kiely, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 6, 2026
Interleukin-6 is critical in the development of pulmonary vascular disease in Gcn2-deficient miceMax Schwiening, Qingyue Gao, Mark Southwood, et al.
Pageof 8